40 results match your criteria: "Deaconess Hospital and Harvard Medical School[Affiliation]"
Nature
March 2024
Department of Biology, The David H. Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, MA, USA.
A hallmark of cancer is the avoidance of immune destruction. This process has been primarily investigated in locally advanced or metastatic cancer; however, much less is known about how pre-malignant or early invasive tumours evade immune detection. Here, to understand this process in early colorectal cancers (CRCs), we investigated how naive colon cancer organoids that were engineered in vitro to harbour Apc-null, Kras and Trp53-null (AKP) mutations adapted to the in vivo native colonic environment.
View Article and Find Full Text PDFBrain Tumor Res Treat
April 2023
Department of Neurosurgery, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA, USA.
Background: Cerebral chondrosarcoma metastases are rare and aggressive neoplasms. The rarity of presentation has precluded rigorous analysis of diagnosis, risk factors, treatment, and survival. We analyzed every reported case through exhaustive literature review.
View Article and Find Full Text PDFNeurogastroenterol Motil
June 2022
Department of Medicine, Divisions of Gastroenterology and Hepatology. VA Boston Healthcare System, Beth Israel Deaconess Hospital and Harvard medical School, Boston, Massachusetts, USA.
Gastro Hep Adv
February 2022
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Background And Aims: Fecal calprotectin (FC) is a noninvasive biomarker used in inflammatory bowel disease (IBD) management and risk stratification of nonspecific gastrointestinal symptoms. Leukocyte esterase is an inexpensive and widely available point-of-care inflammatory marker present on urinalysis test strips. We aim to assess the diagnostic accuracy of fecal leukocyte esterase (FLE) relative to FC and endoscopy and demonstrate its use as an alternative biomarker for IBD.
View Article and Find Full Text PDFJ Neuropathol Exp Neurol
December 2021
Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Meningioma is the most common primary central nervous system tumor. Although mostly nonmalignant, meningioma can cause serious complications by mass effect and vasogenic edema. While surgery and radiation improve outcomes, not all cases can be treated due to eloquent location.
View Article and Find Full Text PDFFront Psychiatry
September 2020
Department of Psychiatry, State University of New York Upstate Medical University, Syracuse, NY, United States.
Background: Neonatal abstinence syndrome (NAS) is common, expensive, and hurts opioid addicted women and their families. Current treatments do not sufficiently address comorbid addictions, especially tobacco use, among pregnant buprenorphine-maintained women.
Methods: 25 consecutive admissions of pregnant, opioid addicted women were treated with buprenorphine maintenance and a novel intervention for pregnant opioid addicted patients, Drug Use Targeted Therapy (DUST).
Mol Clin Oncol
December 2020
Department of Neurology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA 02215, USA.
The median survival time of patients with glioblastoma is 14-16 months with a 5-year overall survival rate of 9.8%. Standard of care treatment includes radiation with concomitant temozolomide followed by cyclic temozolomide.
View Article and Find Full Text PDFJ Am Acad Dermatol
January 2018
Baylor University Medical Center at Dallas, Dallas, Texas.
Background: Patients with psoriasis are at an increased risk for depression. However, the impact of treatment on this risk is unclear.
Objective: Evaluate the incidence and impact of treatment on depression among patients with moderate-to-severe psoriasis.
Acta Derm Venereol
January 2018
Beth Israel Deaconess Hospital and Harvard Medical School, 375 Longwood Ave, Boston, MA 02215, USA.
Itching is a prevalent plaque psoriasis symptom. Ixekizumab, an IL-17A antagonist, has demonstrated rapid, significant improvements in itch severity over 12 weeks in Phase III psoriasis trials (UNCOVER-1, UNCOVER-2). We assessed the long-term (through 60 weeks) effect of ixekizumab maintenance therapy (80-mg ixekizumab every 4 weeks [IXEQ4W]) on itch severity, using the Itch Numeric Rating Scale, in psoriasis patients who received ixekizumab, placebo, or etanercept for 12 weeks in the Phase III UNCOVER-3 trial.
View Article and Find Full Text PDFPLoS One
July 2017
Division of Infectious Diseases, Brown University, Providence, Rhode Island, United States of America.
Background: The HIV epidemic in the United States (US) disproportionately affects gay, bisexual, and other men who have sex with men (MSM). Pre-exposure prophylaxis (PrEP) using co-formulated tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) has demonstrated high efficacy in reducing HIV incidence among MSM. However, low adherence was reported in major efficacy trials and may present a substantial barrier to successful PrEP implementation.
View Article and Find Full Text PDFAnn Thorac Surg
October 1998
Beth Israel Deaconess Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Otolaryngol Head Neck Surg
March 1998
Department of Otology and Laryngology, New England Deaconess Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Transplantation
March 1997
Department of Pathology, Deaconess Hospital and Harvard Medical School, Boston, Massachusetts 02215, USA.
Background: Refractory rejection and cyclosporine (CsA)-induced nephropathy remain important causes of renal allograft loss. Previous studies demonstrated that 70-85% of the episodes of refractory acute rejection (AR) occurring in renal allograft recipients on a CsA-based immunosuppressive regimen could be salvaged by conversion to tacrolimus. No data are available regarding the correlation between allograft histology at the time of conversion and the response to tacrolimus.
View Article and Find Full Text PDFAm Surg
January 1997
Deaconess Hospital and Harvard Medical School, Boston, Massachusetts 02215, USA.
Under the impact of mammographic screening, sizeable proportions of breast cancer patients today are nonpalpable with either a very small invasive breast cancer (T1a or T1b) or ductal carcinoma in situ. At the Deaconess Hospital in Boston between 1989 and 1993, 29 per cent of all invasive cancers were T1a or T1b (1 cm or smaller). The median maximum diameter of all invasive breast cancer in that 5-year period was only 1.
View Article and Find Full Text PDFTransplantation
December 1996
Sandoz Center for Immunobiology, New England Deaconess Hospital and Harvard Medical School, Boston, Massachusetts 02215, USA.
Platelet thrombi and vascular inflammation are prominent features of discordant xenograft rejection. The purinergic nucleotides ATP and ADP, which are secreted from platelets and released by injured endothelial cells (EC), are important mediators of these reactions. Quiescent EC express the ectoenzyme ATP-diphosphohydrolase (ATPDase; an apyrase), which exerts an important thromboregulatory function by hydrolyzing both ATP and ADP.
View Article and Find Full Text PDFN Engl J Med
November 1996
Division of Infectious Diseases, Deaconess Hospital and Harvard Medical School, Boston, MA 02215, USA.
Cancer Res
October 1996
Laboratory of Cancer Biology, Department of Surgery, Deaconess Hospital and Harvard Medical School, Boston, Massachusetts 02215, USA.
The mechanism by which carcinoembryonic antigen (CEA) causes enhancement of hepatic metastasis from colorectal cancer is not defined. We hypothesize that binding of CEA to an 80-kDa Kupffer cell receptor by the peptide sequence Pro-Glu-Leu-Pro-Lys (PELPK) induces cytokine production in the hepatic microenvironment, which then impacts on the formation of hepatic metastasis from colorectal cancer. We have, therefore, isolated Kupffer cells and treated them in vitro with CEA, its gene family member nonspecific cross-reacting antigen, PELPK-albumin conjugate, and lipopolysaccharide as a positive control.
View Article and Find Full Text PDFArch Biochem Biophys
October 1996
Laboratory of Cancer Biology, Department of Surgery, Deaconess Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Carcinoembryonic antigen (CEA) binds to an 80-kDa cell surface receptor on Kupffer cells via the peptide sequence PELPK (residues 108-112) located at the hinge region between the N and Al immunoglobulin-like domains. This study is aimed at analyzing the specificity of the peptide binding, determining biodistribution of 80-kDa receptor, and processing of CEA by this receptor. We synthesized a number of bovine serum albumin (BSA) derivatives carrying PELPK and related sequences.
View Article and Find Full Text PDFAbdom Imaging
November 1996
Department of Radiological Sciences, Deaconess Hospital and Harvard Medical School, 1 Deaconess Road, Boston, MA 02115, USA.
Primary melanoma is rarely diagnosed in the biliary tract; only three cases of primary melanoma of the bile ducts have been reported previously. The skin and squamous mucous membranes are the most common primary sites. We report two patients who represent the fourth and fifth reported cases of primary bile duct melanoma.
View Article and Find Full Text PDFCardiovasc Intervent Radiol
October 1996
Department of Radiological Sciences, Deaconess Hospital and Harvard Medical School, 1 Deaconess Road, Boston, MA 02215, USA.
Purpose: To determine the efficacy of the transfemoral vein approach to repositioning malpositioned central venous catheters.
Methods: During a 4(1/2)-year period, malpositioned central venous catheters were repositioned 91 times in 83 patients via the transfemoral vein approach. All repositioning was initially attempted with a Grollman catheter or other pigtail catheter and a tip-deflecting wire.
J Thorac Cardiovasc Surg
July 1996
Division of Cardiothoracic Surgery, New England Deaconess Hospital and Harvard Medical School, Boston, MA, USA.
Objective: The effect of cardioplegic solutions with high concentrations of potassium or magnesium (or both) on cytosolic calcium accumulation was investigated with fura-2 in isolated perfused mature (n = 24) and aged (n = 24) rabbit hearts.
Methods: We compared cytosolic calcium accumulation before ischemia (control), during 30 minutes of ischemia and 30 minutes of reperfusion under global ischemia, or after treatment with potassium (20 mmol/L), magnesium (20 mmol/L), or both.
Results: Cytosolic calcium accumulation was increased during global ischemia in the mature heart (from 178.
JAMA
June 1996
New England Deaconess Hospital and Harvard Medical School, Boston, Mass, USA.
Arch Biochem Biophys
April 1996
Laboratory of Cancer Biology, Deaconess Hospital and Harvard Medical School, Boston, Massachussetts 02115, USA.
The receptor-mediated interaction of Kupffer cells with carcinoembryonic antigen (CEA) has led to the identification of an 80-kDa CEA-binding Kupffer cell protein. This study is aimed at the isolation and analyses of this protein from rat Kupffer cells. The binding protein was purified using a combination of gel filtration, preparative polyacrylamide gel electrophoresis (PPAGE), and affinity chromatography using a CEA-Sepharose column.
View Article and Find Full Text PDFDiabetes
March 1996
Division of Organ Transplantation, Department of Surgery, Deaconess Hospital and Harvard Medical School, Boston, MA, USA.
Tight glycemic control by intensive insulin therapy effectively delays the onset and slows the progression of diabetic complications but is associated with frequent dose adjustments and a high incidence of hypoglycemia. Successful pancreas transplantation corrects abnormal glucose metabolism but subjects patients to morbidity and mortality associated with chronic immunosuppression. A vascularized artificial pancreas device containing pancreatic islets is designed to provide glycemic control without immunosuppression.
View Article and Find Full Text PDF